AIImpactLab
9 impact clustersWork & marketsCognition & learningTechnical failuresPrivacySecurityEnvironmentLaw & informationSocial good & healthSystemic risk
Search the evidence

Find the signal.

Search titles, impact clusters, countries, organizations and the full text of every analysis.

4 stories found

Work & marketsGlobal+2 clusters01

Huang et al., “Autonomous biomedical research with an artificial intelligence agent”

The paper introduces Biomni, a general-purpose biomedical agent that can search literature, formulate hypotheses, select datasets and specialized tools, write analytical code, interpret results, and propose subsequent experiments within an integrated workflow. Stanford reports that a prototype is already used by more than 10,000 laboratories; in one example, it processed over 450 wearable-health files and generated plausible findings in 40 minutes, compared with an estimated 60 or more hours of human work.

2 min
A grocery shopper faces variable price labels beside a biomedical researcher reviewing abstract dataset screens.
Work & marketsGlobal+3 clusters02

AI can change your price and speed science. Who gets the gain?

The same word, efficiency, can hide two very different experiences. CBS examines the prospect of AI-enabled individualized pricing: a retailer can learn what different shoppers may be willing to pay while the shopper loses a stable point of comparison. It cites a 2025 Instacart experiment. Consumer Reports' corrected finding is a maximum 23% price difference for a single item in its synchronized tests, not for an entire basket; CBS's basket wording should not be repeated as fact. Instacart says the test did not use personal characteristics to set prices, disputes the annualized family-cost estimate, and ended the item-price experiment in December 2025. Walmart also denies using personal data to set individualized prices; patent filings alone do not establish deployed practice. In a separate peer-reviewed Scientific Data study, researchers used four language models to screen biomedical datasets across three repositories and disease settings. They report a median screening time of six minutes, with the best individual models reaching held-out sensitivity around 88% to 93% and specificity varying from 85.1% to 99.1%. Ensemble decisions reached 100% sensitivity in the evaluated settings, not a general guarantee. These are separate technologies and evidence streams, not one causal story. Put together, they make a sharper question: when AI cuts friction, does the benefit reach the person whose life is affected? A shopper needs transparent, comparable prices; a scientist needs auditable false negatives and human review. Speed alone cannot answer either question.

7 min
A federal AI and supercomputing hub connecting health data, drug discovery, infrastructure materials, and scientific research.
Social good & healthUnited States+3 clusters03

A $5 billion federal push links AI to health, infrastructure and science

The U.S. government has committed more than $5 billion to expand the Genesis Mission, a multi-agency effort that combines federal datasets, Department of Energy supercomputers, research facilities, and AI tools. More than 15 agencies and 278 selected projects will target problems including chronic disease, pediatric cancer, drug discovery, resilient building materials, transportation maintenance, energy, manufacturing, agriculture, and national security.

3 min
Technical failuresGlobal+1 clusters04

TRUECAM uncertainty-aware cancer-diagnostics framework

Nature Biomedical Engineering published a lung-cancer pathology AI paper introducing TRUECAM, a framework that detects out-of-scope inputs, filters ambiguous regions, and uses conformal prediction to control error rates; the authors report gains in accuracy, robustness, interpretability, data efficiency, and fairness across datasets and foundation models. its significance is less “AI replaces diagnosis” than “AI deployment requires uncertainty, fairness, and error-control layers.”

2 min